Profusa is a pioneering company based in San Francisco, CA that specializes in the development of tissue-integrating biosensors for continuous monitoring of body chemistries. Their innovative Lumee Oxygen Platform, which has received CE Mark approval in the European Union, allows for real-time monitoring of tissue oxygen levels, enabling potential applications in telehealth, remote patient monitoring, and clinical management of various medical conditions.
With a strong focus on innovation and cutting-edge technology, Profusa has been recognized for their groundbreaking work in the biochemical sensors market. Their wireless Lumee Oxygen Platform, along with their glucose biosensors, has garnered attention from global investors and industry experts, positioning Profusa as a leader in the field of real-time body chemistry monitoring. Through ongoing research and partnerships, Profusa continues to push the boundaries of medical technology, offering potential solutions for early detection, prediction, and improved management of various health conditions.
Generated from the website